840058 | Hydro Soy PC
L-α-phosphatidylcholine, hydrogenated (Soy)

Hydro Soy PC
L-α-phosphatidylcholine, hydrogenated (Soy)
CAS Registry Number is a Registered Trademark of the American Chemical Society
lecithin
Vera-González N, Bailey-Hytholt CM, Langlois L, de Camargo Ribeiro F, de Souza Santos EL, Junqueira JC, Shukla A. Anidulafungin liposome nanoparticles exhibit antifungal activity against planktonic and biofilm Candida albicans. J Biomed Mater Res A. 2020 May 3. doi: 10.1002/jbm.a.36984. Epub ahead of print. PMID: 32363762.
PubMed ID: 32363762Gaál A, Garay TM, Horváth I, Máthé D, Szöllősi D, Veres DS, Mbuotidem J, Kovács T, Tóvári J, Bergmann R, Streli C, Szakács G, Mihály J, Varga Z, Szoboszlai N. Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation. Pharmaceutics. 2020 May 20;12(5):466. doi: 10.3390/pharmaceutics12050466. PMID: 32443790; PMCID: PMC7284829.
PubMed ID: 32443790Dadwal A, Mishra N, Rawal RK, Narang RK. Development and characterisation of clobetasol propionate loaded Squarticles as a lipid nanocarrier for treatment of plaque psoriasis. J Microencapsul. 2020 Apr 23:1-14. doi: 10.1080/02652048.2020.1756970. Epub ahead of print. PMID: 32293928.
PubMed ID: 32293928Mutlu-Agardan NB, Yilmaz S, Kaynak Onurdag F, Celebi N. Development of effective AmB/AmB-αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment. J Liposome Res. 2020 May 21:1-12. doi: 10.1080/08982104.2020.1755980. Epub ahead of print. PMID: 32290745.
PubMed ID: 32290745Chen ZJ, Yang SC, Liu XL, Gao Y, Dong X, Lai X, Zhu MH, Feng HY, Zhu XD, Lu Q, Zhao M, Chen HZ, Lovell JF, Fang C. Nanobowl-Supported Liposomes Improve Drug Loading and Delivery. Nano Lett. 2020 May 20. doi: 10.1021/acs.nanolett.0c00495. Epub ahead of print. PMID: 32431154.
PubMed ID: 32431154Weiss LE, Shalev Ezra Y, Goldberg S, Ferdman B, Adir O, Schroeder A, Alalouf O, Shechtman Y. Three-dimensional localization microscopy in live flowing cells. Nat Nanotechnol. 2020 Apr 20. doi: 10.1038/s41565-020-0662-0. Epub ahead of print. PMID: 32313220.
PubMed ID: 32313220Karimi M, Gheybi F, Zamani P, Mashreghi M, Golmohammadzadeh S, Darban SA, Badiee A, Jaafari MR. Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study. Int J Pharm. 2020 Apr 30;580:119211. doi: 10.1016/j.ijpharm.2020.119211. Epub 2020 Mar 7. PMID: 32156530.
PubMed ID: 32156530Gurung S, Khan F, Gunassekaran GR, Yoo JD, Poongkavithai Vadevoo SM, Permpoon U, Kim SH, Kim HJ, Kim IS, Han H, Park JH, Kim S, Lee B. Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression. Biomaterials. 2020 Jul;247:119984. doi: 10.1016/j.biomaterials.2020.119984. Epub 2020 Mar 20. PMID: 32278214.
PubMed ID: 32278214Drabik D, Chodaczek G, Kraszewski S, Langner M. Mechanical Properties Determination of DMPC, DPPC, DSPC, and HSPC Solid-Ordered Bilayers. Langmuir. 2020 Mar 24. doi: 10.1021/acs.langmuir.0c00475. Epub ahead of print. PMID: 32176506.
PubMed ID: 32176506Blazaki S, Pachis K, Tzatzarakis M, Tsilimbaris M, Antimisiaris SG. Novel Liposome Aggregate Platform (LAP) system for sustained retention of drugs in the posterior ocular segment following intravitreal injection. Int J Pharm. 2019 Dec 21;576:118987. doi: 10.1016/j.ijpharm.2019.118987. [Epub ahead of print]. PMID: 31870961.
PubMed ID: 31870961Lin M, Guo W, Zhang Z, Zhou Y, Chen J, Wang T, Zhong X, Lu Y, Yang Q, Wei Q, Han M, Xu D, Gao J. Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models. Mol Pharm. 2019 Dec 27;10.1021/acs.molpharmaceut.9b00928. doi: 10.1021/acs.molpharmaceut.9b00928. [Epub ahead of print]. PMID: 31825633.
PubMed ID: 31825633Weiss VU, Balantic K, Pittenauer E, Tripisciano C, Friedbacher G, Weber V, Marchetti-Deschmann M, Allmaier G. Nano electrospray differential mobility analysis based size-selection of liposomes and very-low density lipoprotein particles for offline hyphenation to MALDI mass spectrometry. J Pharm Biomed Anal. 2020 Feb 5;179:112998. doi: 10.1016/j.jpba.2019.112998. Epub 2019 Nov 18.
PubMed ID: 31780280Naziris N, Saitta F, Chrysostomou V, Libera M, Trzebicka B, Fessas D, Pispas S, Demetzos C. pH-responsive chimeric liposomes: From nanotechnology to biological assessment. Int J Pharm. 2020 Jan 25;574:118849. doi: 10.1016/j.ijpharm.2019.118849. Epub 2019 Nov 20.
PubMed ID: 31759107Zheng Z, Ji H, Zong W, Ran Q, Wang X, Yang X, Zhao Z, Yang C, Xiao Y. Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3. AMB Express. 2019 Sep 18;9(1):150. doi: 10.1186/s13568-019-0875-5.
PubMed ID: 31535232Van Haute D, Jiang W, Mudalige T. Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation. Int J Pharm. 2019 Oct 5;569:118603. doi: 10.1016/j.ijpharm.2019.118603. Epub 2019 Aug 8.
PubMed ID: 31401296Lim C, Kang JK, Won WR, Park JY, Han SM, Le TN, Kim JC, Her J, Shin Y, Oh KT. Co-delivery of D-(KLAKLAK)2 Peptide and Chlorin e6 using a Liposomal Complex for Synergistic Cancer Therapy. Pharmaceutics. 2019 Jun 21;11(6). pii: E293. doi: 10.3390/pharmaceutics11060293.
PubMed ID: 31234389Giannakou C, Aimonen K, Bloois LV, Catalán J, Geertsma RE, Gremmer ER, de Jong WH, Keizers PH, Schwillens PL, Vandebriel RJ, Park MV. Sensitive method for endotoxin determination in nanomedicinal product samples. Nanomedicine (Lond). 2019 May;14(10):1231-1246. doi: 10.2217/nnm-2018-0339.
PubMed ID: 31124759Korani M, Ghaffari S, Attar H, Mashreghi M, Jaafari MR. Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma. Nanomedicine. 2019 May 16;20:102013. doi: 10.1016/j.nano.2019.04.016. [Epub ahead of print]
PubMed ID: 31103736Davis MS, Marrero-Berrios I, Perez XI, Rabolli CP, Radhakrishnan P, Manchikalapati D, Schianodicola J, Kamath H, Schloss RS, Yarmush J. Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy. J Inflamm Res. 2019 Mar 12;12:87-97. doi: 10.2147/JIR.S192749. eCollection 2019.
PubMed ID: 30881083Stefanick JF, Omstead DT, Kiziltepe T, Bilgicer B. Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity. Nanoscale. 2019 Mar 7;11(10):4414-4427. doi: 10.1039/c8nr09431d.
PubMed ID: 30801591Lin TW, Chien Y, Lin YY, Wang ML, Yarmishyn AA, Yang YP, Hwang DK, Peng CH, Hsu CC, Chen SJ, Chien KH. Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization. Int J Mol Sci. 2019 Jan 9;20(2). pii: E241. doi: 10.3390/ijms20020241.
PubMed ID: 30634448Chen M, Song F, Liu Y, Tian J, Liu C, Li R, Zhang Q. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer. Nanoscale. 2019 Mar 7;11(9):3814-3826. doi: 10.1039/c8nr06218h. Epub 2019 Jan 2.
PubMed ID: 30600823This Natural Lipid is a mixture and the structure shown above is only representative of one possible structure present in the product. Refer to chart for average fatty acid distribution.

- Certificate of Analysis (Lot No. 840058P-1G-A-037 and 5513PQA037)
- Certificate of Analysis (Lot No. 840058P-200MG-A-037 and 5513PNA037)
- Certificate of Analysis (Lot No. 840058P-25MG-A-037 and 5513PJA037)
- Certificate of Analysis (Lot No. 840058P-500MG-A-037 and 5513PPA037)
- Certificate of Analysis (Lot No. 840058P-1G-B-037 and 5513PQB037)
- Certificate of Analysis (Lot No. 840058P-200MG-B-037 and 5513PNB037)
- Certificate of Analysis (Lot No. 840058P-500MG-A-038 and 5513PPA038)
- Certificate of Analysis (Lot No. 840058P-500MG-B-038 and 5513PPB038)
- Certificate of Analysis (Lot No. 840058P-1G-A-038 and 5513PQA038)
- Certificate of Analysis (Lot No. 840058P-5G-A-038 and 5513PWA038)
- Certificate of Analysis (Lot No. 840058P-1G-A-039 and 5513PQA039)
- Certificate of Analysis (Lot No. 840058P-500MG-C-038 and 5513PPC038)
- Certificate of Analysis (Lot No. 840058P-200MG-A-038 and 5513PNA038)
- Certificate of Analysis (Lot No. 840058P-1G-B-039 and 5513PQB039)
- Certificate of Analysis (Lot No. 840058P-1G-C-039 and 5513PQC039)
- Certificate of Analysis (Lot No. 840058P-200MG-A-039 and 5513PNA039)
- Certificate of Analysis (Lot No. 840072P-25MG-J-046 and 5523PJJ046)
- Certificate of Analysis (Lot No. 840058P-1G-D-039 and 5513PQD039)
- Certificate of Analysis (Lot No. 840058P-25MG-A-039 and 5513PJA039)
- Certificate of Analysis (Lot No. 840058P-200MG-B-039 and 5513PNB039)
- Certificate of Analysis (Lot No. 840058P-1G-E-039 and 5513PQE039)
- Certificate of Analysis (Lot No. 840058P-200MG-C-039 and 5513PNC039)
- Certificate of Analysis (Lot No. 840058P-25MG-B-039 and 5513PJB039)
- Certificate of Analysis (Lot No. 840058P-200MG-G-039 and 5513PNG039)
- Certificate of Analysis (Lot No. 840058P-25MG-C-039 and 5513PJC039)
- Certificate of Analysis (Lot No. 840058P-1G-A-040 and 5513PQA040)
- Certificate of Analysis (Lot No. 840058P-200MG-D-039 and 5513PND039)
- Certificate of Analysis (Lot No. 840058P-200MG-A-040 and 5513PNA040)
- Certificate of Analysis (Lot No. 840058P-25MG-A-040 and 5513PJA040)
- Certificate of Analysis (Lot No. 840058P-1G-A-041 and 5513PQA041)
- Certificate of Analysis (Lot No. 840058P-200MG-B-040 and 5513PNB040)
- Certificate of Analysis (Lot No. 840058P-500MG-B-041 and 5513PPB041)
- Certificate of Analysis (Lot No. 840058P-1G-B-041 and 5513PQB041)
- Certificate of Analysis (Lot No. 840058P-200MG-B-041 and 5513PNB041)
- Certificate of Analysis (Lot No. 840058P-200MG-A-041 and 5513PNA041)
- Certificate of Analysis (Lot No. 840058P-25MG-A-041 and 5513PJA041)
- Certificate of Analysis (Lot No. 840058P-500MG-C-041 and 5513PPC041)
- Certificate of Analysis (Lot No. 840058P-25MG-B-041 and 5513PJB041)
- Certificate of Analysis (Lot No. 840058P-500MG-D-041 and 5513PPD041)
- Certificate of Analysis (Lot No. 840058P-1G-C-041 and 5513PQC041)
- Certificate of Analysis (Lot No. 840058P-200MG-C-041 and 5513PNC041)
- Certificate of Analysis (Lot No. 840058P-25MG-C-041 and 5513PJC041)
- Certificate of Analysis (Lot No. 840058P-25MG-D-041 and 5513PJD041)
- Certificate of Analysis (Lot No. 840058P-200MG-D-041 and 5513PND041)